$511 Million is the total value of GREAT POINT PARTNERS LLC's 40 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 63.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $34,578,713 | +19.7% | 3,363,688 | -10.1% | 6.77% | +19.4% |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $31,249,661 | +15.0% | 677,426 | 0.0% | 6.12% | +14.7% | |
| PCVX | Sell | VAXCYTE INC | $29,425,197 | +19.1% | 589,211 | -10.6% | 5.76% | +18.7% |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $28,089,334 | -12.9% | 1,550,184 | +27.9% | 5.50% | -13.1% |
| RAPT | Buy | RAPT THERAPEUTICS INC | $27,398,324 | +10.2% | 1,465,151 | +8.1% | 5.36% | +9.9% |
| PNT | Sell | POINT BIOPHARMA GLOBAL INC | $27,180,000 | +10.5% | 3,000,000 | -11.3% | 5.32% | +10.2% |
| New | ZURA BIO LTD | $27,019,000 | – | 3,295,000 | +100.0% | 5.29% | – | |
| Buy | AMYLYX PHARMACEUTICALS INC | $20,896,908 | -9.1% | 968,795 | +23.6% | 4.09% | -9.4% | |
| XENE | Sell | XENON PHARMACEUTICALS INC | $20,405,000 | -30.3% | 530,000 | -35.2% | 3.99% | -30.6% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $20,134,195 | +108.9% | 1,941,581 | +62.9% | 3.94% | +108.2% |
| CYTK | Buy | CYTOKINETICS INC | $19,572,000 | +11.2% | 600,000 | +20.0% | 3.83% | +10.9% |
| ANAB | Buy | ANAPTYSBIO INC | $18,190,733 | +3.9% | 894,333 | +11.2% | 3.56% | +3.6% |
| IMCR | Buy | IMMUNOCORE HLDGS PLCads | $17,813,037 | +41.1% | 297,082 | +16.3% | 3.49% | +40.7% |
| EOLS | Buy | EVOLUS INC | $17,695,529 | -4.6% | 2,434,048 | +11.0% | 3.46% | -4.9% |
| AVTE | Buy | AEROVATE THERAPEUTICS INC | $15,986,510 | +4.9% | 932,158 | +23.4% | 3.13% | +4.6% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $14,154,672 | – | 123,600 | +100.0% | 2.77% | – |
| ALKS | New | ALKERMES PLC | $12,878,479 | – | 411,453 | +100.0% | 2.52% | – |
| RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $12,730,280 | +631.5% | 772,000 | +691.4% | 2.49% | +628.7% |
| OPTN | Buy | OPTINOSE INC | $10,873,125 | -28.6% | 8,839,939 | +12.0% | 2.13% | -28.8% |
| VKTX | Sell | VIKING THERAPEUTICS INC | $9,702,496 | -41.7% | 598,550 | -40.1% | 1.90% | -41.9% |
| Sell | MINERALYS THERAPEUTICS INC | $9,310,306 | -4.2% | 546,059 | -12.0% | 1.82% | -4.4% | |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $8,809,484 | +109.0% | 701,392 | +84.6% | 1.72% | +108.6% |
| GRCL | Sell | GRACELL BIOTECHNOLOGIES INCsponsored ads | $8,641,297 | +47.3% | 2,268,057 | -28.1% | 1.69% | +46.9% |
| APLS | New | APELLIS PHARMACEUTICALS INCput | $8,627,170 | – | 94,700 | +100.0% | 1.69% | – |
| RPHM | Buy | RENEO PHARMACEUTICALS INC | $7,106,560 | +883.2% | 1,083,317 | +796.3% | 1.39% | +879.6% |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $6,650,621 | – | 601,322 | +100.0% | 1.30% | – |
| FDMT | New | 4D MOLECULAR THERAPEUTICS IN | $6,324,500 | – | 350,000 | +100.0% | 1.24% | – |
| GBIO | GENERATION BIO CO | $5,623,954 | +27.9% | 1,022,537 | 0.0% | 1.10% | +27.6% | |
| HRTX | Sell | HERON THERAPEUTICS INC | $5,495,347 | -37.4% | 4,737,368 | -18.6% | 1.08% | -37.6% |
| ABOS | ACUMEN PHARMACEUTICALS INC | $5,056,594 | +18.5% | 1,051,267 | 0.0% | 0.99% | +18.1% | |
| IGMS | New | IGM BIOSCIENCES INC | $4,615,000 | – | 500,000 | +100.0% | 0.90% | – |
| MCRB | New | SERES THERAPEUTICS INC | $4,493,341 | – | 938,067 | +100.0% | 0.88% | – |
| DTIL | Sell | PRECISION BIOSCIENCES INC | $3,929,081 | -35.6% | 7,469,736 | -7.8% | 0.77% | -35.8% |
| Buy | SOLID BIOSCIENCES INC | $3,062,560 | +207.1% | 584,458 | +177.8% | 0.60% | +206.1% | |
| ACRS | New | ACLARIS THERAPEUTICS INCput | $2,644,350 | – | 255,000 | +100.0% | 0.52% | – |
| TALS | New | TALARIS THERAPEUTICS INC | $2,024,740 | – | 666,033 | +100.0% | 0.40% | – |
| Sell | ARCELLX INC | $1,185,750 | -85.0% | 37,500 | -85.4% | 0.23% | -85.1% | |
| TVTX | Sell | TRAVERE THERAPEUTICS INC | $921,600 | -95.9% | 60,000 | -94.0% | 0.18% | -95.9% |
| MRSN | New | MERSANA THERAPEUTICS INCcall | $230,300 | – | 70,000 | +100.0% | 0.04% | – |
| XENE | New | XENON PHARMACEUTICALS INCput | $103,950 | – | 2,700 | +100.0% | 0.02% | – |
| URGN | Exit | UROGEN PHARMA LTD | $0 | – | -39,222 | -100.0% | -0.07% | – |
| Exit | AVALO THERAPEUTICS INC | $0 | – | -474,639 | -100.0% | -0.16% | – | |
| VKTX | Exit | VIKING THERAPEUTICS INCput | $0 | – | -80,000 | -100.0% | -0.26% | – |
| PRAX | Exit | PRAXIS PRECISION MEDICINES I | $0 | – | -2,032,550 | -100.0% | -0.32% | – |
| DAWN | Exit | DAY ONE BIOPHARMACEUTICALS I | $0 | – | -141,526 | -100.0% | -0.37% | – |
| KMPH | Exit | ZEVRA THERAPEUTICS INC | $0 | – | -347,824 | -100.0% | -0.38% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INCcall | $0 | – | -250,000 | -100.0% | -0.40% | – |
| ETNB | Exit | 89BIO INC | $0 | – | -250,000 | -100.0% | -0.75% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INC | $0 | – | -70,371 | -100.0% | -0.75% | – |
| LRMR | Exit | LARIMAR THERAPEUTICS INC | $0 | – | -900,000 | -100.0% | -0.80% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -507,500 | -100.0% | -0.87% | – |
| Exit | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $0 | – | -278,334 | -100.0% | -1.17% | – | |
| RLAY | Exit | RELAY THERAPEUTICS INC | $0 | – | -658,127 | -100.0% | -2.13% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -1,600,545 | -100.0% | -2.47% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -694,009 | -100.0% | -3.32% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLC | $0 | – | -149,500 | -100.0% | -4.30% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTNS, INC CMN | 25 | Q3 2019 | 2.5% |
| IOVANCE BIOTHERAPEUTICS, INC. CMN | 16 | Q1 2021 | 14.3% |
| ZOGENIX INC CMN | 16 | Q4 2019 | 8.8% |
| PTC THERAPEUTICS, INC. CMN | 16 | Q3 2023 | 9.9% |
| EXELIXIS, INC | 16 | Q1 2022 | 7.5% |
| SAGE THERAPEUTICS, INC CMN | 15 | Q3 2021 | 10.8% |
| CYTOKINETICS INC | 15 | Q3 2023 | 5.8% |
| ACADIA PHARMACEUTICALS, INC. | 14 | Q1 2021 | 8.8% |
| ACCELERON PHARMA INC CMN | 14 | Q2 2020 | 8.2% |
| CONNECTURE INC | 13 | Q4 2017 | 25.1% |
View GREAT POINT PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 89bio, Inc. | February 14, 2023 | 700,000 | 1.4% |
| KalVista Pharmaceuticals, Inc. | February 14, 2023 | 1,055,801 | 3.1% |
| Avalo Therapeutics, Inc. | February 13, 2023 | 974,639 | 7.1% |
| InflaRx N.V.Sold out | February 14, 2022 | 0 | 0.0% |
| ABEONA THERAPEUTICS INC.Sold out | February 16, 2021 | 0 | 0.0% |
| CONSTELLATION PHARMACEUTICALS INC | February 16, 2021 | 1,024,800 | 2.2% |
| GERON CORP | February 16, 2021 | 12,754,228 | 4.0% |
| Millendo Therapeutics, Inc. | February 16, 2021 | 270,000 | 1.4% |
| NextCure, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | February 16, 2021 | 977,647 | 2.4% |
View GREAT POINT PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View GREAT POINT PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.